Industry Press Releases

NTRR: Cannabis topicals could revolutionize sports training and recovery

Wednesday, Dec 30, 2015
Pressreleases

Muscle stiffness, soreness and fatigue are challenges that every athlete is all too familiar with. Now, with the help of its new joint venture partner, Neutra Corp., is working to deliver superior new solutions to the aches and pains faced by athletes every day.

And the all-natural key to easing muscle discomfort and improving athletic performance, the company believes, is cannabis.

“More and more athletes are turning to cannabis-infused topical products such as lotions, balm and sprays because they’re fast-acting, long-lasting and just plain effective,” said NTRR CEO Chris Brown. “There is no better all-natural treatment for workout-related pain relief, and the market for these products is projected to explode as the regulated cannabis industry continues to spread across North America.”

Cannabis topicals have been lauded by athletes for their analgesic, anti-inflammatory and antimicrobial properties. As their usage spreads, their popularity grows—cannabis topicals could be on the verge of becoming standard post-workout treatments for athletes everywhere.

NTRR has big plans to capitalize on the trend. Earlier this month, the company made a play to enter the booming market for innovative, cannabis-infused topical products by forming a joint venture with Oceanview Health Services Ltd., a Canadian nutraceuticals company focused on providing new medicinal solutions utilizing cannabinoids. In 2016, NTRR plans to deliver many new offerings for cannabis producers and consumers alike as demand for CBD products and services grows by the day.

About Neutra Corp. :

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals , INSYS Therapeutics, Inc.,  and ENDEXX Corp., delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements :

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contacts :

Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com

 

businesswire.com

Other Press Releases